|
Rationale and Design of Apabetalone BETonMACE Trial
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 03:32PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 02, 2018 05:44PM
|
|
Re: Patient Enrollment Modeling
|
1
|
Resverlogix Corp.
|
Dec 02, 2018 09:32AM
|
|
Re: Patient Enrollment Modeling
|
4
|
Resverlogix Corp.
|
Dec 02, 2018 08:07AM
|
|
Re: Pointing in the right direction & bogus Lilly
|
3
|
Resverlogix Corp.
|
Dec 01, 2018 09:22PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 01, 2018 09:03PM
|
|
Re: Patient Enrollment Modeling
|
3
|
Resverlogix Corp.
|
Dec 01, 2018 08:33PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
1
|
Resverlogix Corp.
|
Dec 01, 2018 04:40PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
1
|
Resverlogix Corp.
|
Dec 01, 2018 04:29PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
4
|
Resverlogix Corp.
|
Dec 01, 2018 03:41PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
3
|
Resverlogix Corp.
|
Dec 01, 2018 03:27PM
|
|
Re: The Pfizer connection...
|
4
|
Resverlogix Corp.
|
Dec 01, 2018 09:16AM
|
|
Re: Can we end November with a bang?
|
3
|
Resverlogix Corp.
|
Nov 30, 2018 03:14PM
|
|
Re: Tundup
|
2
|
Resverlogix Corp.
|
Nov 30, 2018 01:44PM
|
|
Re: Tundup
|
1
|
Resverlogix Corp.
|
Nov 30, 2018 10:20AM
|
|
Re: Pointing in the right direction & bogus Lilly
|
4
|
Resverlogix Corp.
|
Nov 30, 2018 09:02AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
2
|
Resverlogix Corp.
|
Nov 29, 2018 11:49AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
3
|
Resverlogix Corp.
|
Nov 29, 2018 11:01AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
1
|
Resverlogix Corp.
|
Nov 29, 2018 10:38AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
4
|
Resverlogix Corp.
|
Nov 28, 2018 10:39AM
|
